All Stories

  1. Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan–Amoxicillin–Sitafloxacin/Rifabutin Regimens

    Article • Journal of Clinical Medicine, January 2026, MDPI AG

    Dr Juntaro Matsuzaki

  2. Efficacy of Vonoprazan-Based Triple Therapy with Sitafloxacin and Amoxicillin for Third-Line Helicobacter pylori Eradication: A Multicenter Prospective Analysis on Drug Resistance and gyrA Mutations

    Article • Digestive Diseases, June 2025, Karger Publishers

    Dr Juntaro Matsuzaki

  3. Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the CBP/β-catenin inhibitor PRI-724 in patients with liver cirrhosis

    Article • Scientific Reports, March 2024, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  4. Identifying high-grade serous ovarian carcinoma–specific extracellular vesicles by polyketone-coated nanowires

    Article • Science Advances, July 2023, American Association for the Advancement of Science

    Dr Juntaro Matsuzaki

  5. Data from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  6. Data from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  7. Data from Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  8. Data from Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  9. Figure S1-3, Table S1-4 from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  10. Figure S1-3, Table S1-4 from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  11. Supplementary text from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  12. Supplementary text from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  13. Table S1, Table S2, Table S3, Table S4, Table S5, Table S6, Table S7, Table S8, Table S9, Table S10, Table S11, Figure S1, Figure S2, Figure S3, Text from Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  14. Table S1, Table S2, Table S3, Table S4, Table S5, Table S6, Table S7, Table S8, Table S9, Table S10, Table S11, Figure S1, Figure S2, Figure S3, Text from Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

    Article • March 2023, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  15. Evidence forin vitroextensive proliferation of adult hepatocytes and biliary epithelial cells

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Dr Juntaro Matsuzaki

  16. Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers

    Article • Cancer Biomarkers, September 2022, IOS Press

    Dr Juntaro Matsuzaki

  17. Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy

    Article • The Prostate, August 2022, Wiley

    Dr Juntaro Matsuzaki

  18. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma

    Article • Cancer Science, August 2022, Wiley

    Dr Juntaro Matsuzaki

  19. Correction: Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes

    Article • eLife, August 2022, eLife

    Dr Juntaro Matsuzaki

  20. Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐lineHelicobacter pylorieradication regimen

    Article • Helicobacter, May 2022, Wiley

    Dr Juntaro Matsuzaki

  21. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis

    Article • BMJ Open Gastroenterology, April 2022, BMJ

    Dr Juntaro Matsuzaki

  22. Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication

    Article • Annals of Medicine, March 2022, Taylor & Francis

    Dr Juntaro Matsuzaki

  23. Serum microRNA as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer

    Article • International Journal of Urology, March 2022, Wiley

    Dr Juntaro Matsuzaki

  24. Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication

    Article • Annals of Medicine, January 2022, Taylor & Francis

    Dr Juntaro Matsuzaki

  25. Superiority of urgent vs early endoscopic hemostasis in patients with upper gastrointestinal bleeding with high-risk stigmata

    Article • Gastroenterology Report, November 2021, Oxford University Press (OUP)

    Dr Juntaro Matsuzaki

  26. Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma

    Article • Cancer Science, October 2021, Wiley

    Dr Juntaro Matsuzaki

  27. Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review

    Article • Cancers, August 2021, MDPI AG

    Dr Juntaro Matsuzaki

  28. Comprehensive serum and tissue microRNA profiling in dedifferentiated liposarcoma

    Article • Oncology Letters, June 2021, Spandidos Publications

    Dr Juntaro Matsuzaki

  29. Early prediction of COVID‐19 severity using extracellular vesicle COPB2

    Article • Journal of Extracellular Vesicles, June 2021, Wiley

    Dr Juntaro Matsuzaki

  30. A novel combination of serum microRNAs for the detection of early gastric cancer

    Article • Gastric Cancer, March 2021, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  31. Extracellular miRNAs for the Management of Barrett’s Esophagus and Esophageal Adenocarcinoma: A Systematic Review

    Article • Journal of Clinical Medicine, December 2020, MDPI AG

    Dr Juntaro Matsuzaki

  32. Early Prediction of COVID-19 Severity Using Extracellular Vesicles and Extracellular RNAs

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Dr Juntaro Matsuzaki

  33. Horibe GI bleeding prediction score: a simple score for triage decision-making in patients with suspected upper GI bleeding

    Article • Gastrointestinal Endoscopy, September 2020, Elsevier

    Dr Juntaro Matsuzaki

  34. Adenosine leakage from perforin-burst extracellular vesicles inhibits perforin secretion by cytotoxic T-lymphocytes

    Article • PLOS One, April 2020, PLOS

    Dr Juntaro Matsuzaki

  35. A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy

    Article • Communications Biology, March 2020, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  36. Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs

    Article • BMJ Supportive & Palliative Care, January 2020, BMJ

    Dr Juntaro Matsuzaki

  37. Precision Medicine Approaches to Prevent Gastric Cancer

    Article • Gut and Liver, January 2020, The Editorial Office of Gut and Liver

    Dr Juntaro Matsuzaki

  38. Efficacy and safety of immediate oral intake in patients with mild acute pancreatitis: A randomized controlled trial

    Article • Nutrition, January 2020, Elsevier

    Dr Juntaro Matsuzaki

  39. Circulating microRNAs: Next-generation Cancer Detection

    Article • The Keio Journal of Medicine, January 2020, Keio Journal of Medicine

    Dr Juntaro Matsuzaki

  40. Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease

    Article • Hepatology Communications, December 2019, Wolters Kluwer Health

    Dr Juntaro Matsuzaki

  41. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma

    Article • JAMA Network Open, December 2019, American Medical Association (AMA)

    Dr Juntaro Matsuzaki

  42. Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma

    Article • Cancer Science, November 2019, Wiley

    Dr Juntaro Matsuzaki

  43. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, October 2019, IOS Press

    Dr Juntaro Matsuzaki

  44. Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab

    Article • Japanese Journal of Clinical Oncology, October 2019, Oxford University Press (OUP)

    Dr Juntaro Matsuzaki

  45. Brain metastasis-related microRNAs in patients with advanced breast cancer

    Article • PLOS One, October 2019, PLOS

    Dr Juntaro Matsuzaki

  46. Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer

    Article • PLOS One, September 2019, PLOS

    Dr Juntaro Matsuzaki

  47. Transcriptomic Dissection of Hepatocyte Heterogeneity: Linking Ploidy, Zonation, and Stem/Progenitor Cell Characteristics

    Article • Cellular and Molecular Gastroenterology and Hepatology, September 2019, Elsevier

    Dr Juntaro Matsuzaki

  48. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes

    Article • eLife, August 2019, eLife

    Dr Juntaro Matsuzaki

  49. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy

    Article • Digestion, August 2019, Karger Publishers

    Dr Juntaro Matsuzaki

  50. Generation of functional human hepatocytes in vitro: current status and future prospects

    Article • Inflammation and Regeneration, July 2019, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  51. Serum MicroRNA-Based Risk Prediction for Stroke

    Article • Stroke, June 2019, Wolters Kluwer Health

    Dr Juntaro Matsuzaki

  52. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling

    Article • JAMA Network Open, May 2019, American Medical Association (AMA)

    Dr Juntaro Matsuzaki

  53. Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma

    Article • Hepatology Research, May 2019, Wiley

    Dr Juntaro Matsuzaki

  54. Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori–Infected CAPZA1-Overexpressing Cells

    Article • Cellular and Molecular Gastroenterology and Hepatology, May 2019, Elsevier

    Dr Juntaro Matsuzaki

  55. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes

    Article • April 2019, Cold Spring Harbor Laboratory Press

    Dr Juntaro Matsuzaki

  56. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma

    Article • Cell Reports, April 2019, Elsevier

    Dr Juntaro Matsuzaki

  57. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes

    Article • Nature Communications, March 2019, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  58. Large-scale circulating microRNA profiling for the liquid biopsy of prostate cancer

    Article • Clinical Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  59. Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2019, Elsevier

    Dr Juntaro Matsuzaki

  60. Diagnostic Ability of Serum microRNA Classification in Diffuse Glioma: A Retrospective Comprehensive Analysis with Case-Control Study

    Article • SSRN Electronic Journal, January 2019, Elsevier

    Dr Juntaro Matsuzaki

  61. Circulating miRNA panels for specific and early detection in bladder cancer

    Article • Cancer Science, December 2018, Wiley

    Dr Juntaro Matsuzaki

  62. Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma

    Article • United European Gastroenterology Journal, December 2018, SAGE Publications

    Professor Hidekazu Suzuki, Dr Juntaro Matsuzaki

  63. Serum miRNA-based prediction of axillary lymph node metastasis in breast cancer

    Article • Clinical Cancer Research, November 2018, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  64. Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression

    Article • Anticancer Research, November 2018, International Institute of Anticancer Research

    Dr Juntaro Matsuzaki

  65. Integrated extracellular microRNA profiling for ovarian cancer screening

    Article • Nature Communications, October 2018, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  66. Predicting the risk of peripheral neuropathy by the combination of four serum microRNAs

    Article • Annals of Oncology, October 2018, Elsevier

    Dr Juntaro Matsuzaki

  67. Deregulation of CAPZA1 expression increase risk of gastric carcinogenesis.

    Article • Autophagy, September 2018, Taylor & Francis

    Dr Juntaro Matsuzaki, Professor Hidekazu Suzuki, Akira Sato

  68. Gastric cancer: evidence boosts Helicobacter pylori eradication

    Article • Nature Reviews Gastroenterology & Hepatology, April 2018, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  69. Absence of high-risk stigmata predicts good prognosis even in severely anemic patients with suspected acute upper gastrointestinal bleeding

    Article • United European Gastroenterology Journal, April 2018, SAGE Publications

    Dr Juntaro Matsuzaki

  70. Extracellular microRNAs and oxidative stress in liver injury: a systematic mini review

    Article • Journal of Clinical Biochemistry and Nutrition, January 2018, The Society for Free Radical Research Japan

    Dr Juntaro Matsuzaki

  71. Helicobacter pylorieradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk

    Article • Gut, December 2017, BMJ

    Dr Juntaro Matsuzaki

  72. A tissue microRNA signature that predicts the prognosis of breast cancer in young women

    Article • PLOS One, November 2017, PLOS

    Dr Juntaro Matsuzaki

  73. Enteric Glial Dysfunction Evoked by Apolipoprotein E Deficiency Contributes to Delayed Gastric Emptying

    Article • Digestive Diseases and Sciences, November 2017, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  74. Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens

    Article • United European Gastroenterology Journal, October 2017, SAGE Publications

    Dr Juntaro Matsuzaki, Professor Hidekazu Suzuki

  75. Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma

    Article • BMJ Open Gastroenterology, September 2017, BMJ

    Dr Juntaro Matsuzaki

  76. Burden of impaired sleep quality on work productivity in functional dyspepsia

    Article • United European Gastroenterology Journal, August 2017, SAGE Publications

    Dr Juntaro Matsuzaki, Professor Hidekazu Suzuki

  77. Abstract 5678: Novel serum microRNAs that enable liquid biopsy for colorectal cancer: validation study of large cohort

    Article • Cancer Research, July 2017, American Association for Cancer Research (AACR)

    Dr Juntaro Matsuzaki

  78. Impact of Functional Dyspepsia and ITS Concomitant Symptoms on the Loss of Work Productivity

    Article • Gastroenterology, April 2017, Elsevier

    Dr Juntaro Matsuzaki

  79. Serum Micrornas can Detect Colorectal Cancer; two Validation Study after In-Silico Analysis

    Article • Gastroenterology, April 2017, Elsevier

    Dr Juntaro Matsuzaki

  80. Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review

    Article • International Journal of Clinical Oncology, February 2017, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  81. Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients

    Article • United European Gastroenterology Journal, January 2017, SAGE Publications

    Dr Juntaro Matsuzaki, Professor Hidekazu Suzuki

  82. Gender Difference of Gastric Emptying in Healthy Volunteers and Patients with Functional Dyspepsia

    Article • Digestion, January 2017, Karger Publishers

    Dr Juntaro Matsuzaki

  83. Bile Acids and Esophageal Cancer

    Article • January 2017, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  84. A simple scoring system to assess the need for an endoscopic intervention in suspected upper gastrointestinal bleeding: A prospective cohort study

    Article • Digestive and Liver Disease, October 2016, Elsevier

    Dr Juntaro Matsuzaki

  85. A prospective study on symptom generation according to spicy food intake and TRPV1 genotypes in functional dyspepsia patients

    Article • Neurogastroenterology & Motility, April 2016, Wiley

    Dr Juntaro Matsuzaki

  86. Sa1711 The Presence of Sleep Disorders Was Independently Associated With Delayed Gastric Emptying, But Not With the Presence of Functional Dyspepsia

    Article • Gastroenterology, April 2016, Elsevier

    Dr Juntaro Matsuzaki

  87. Novel combination of serum microRNA for detecting breast cancer in the early stage

    Article • Cancer Science, March 2016, Wiley

    Dr Juntaro Matsuzaki

  88. Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia

    Article • Journal of Gastroenterology and Hepatology, January 2016, Wiley

    Dr Juntaro Matsuzaki

  89. Questionnaire-Based Survey on Diagnostic and Therapeutic Endoscopies and H. pylori Eradication for Elderly Patients in East Asian Countries

    Article • Digestion, January 2016, Karger Publishers

    Dr Juntaro Matsuzaki

  90. Symptom Generation

    Article • January 2016, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  91. Influence of regular exercise on gastric emptying in healthy men: a pilot study

    Article • Journal of Clinical Biochemistry and Nutrition, January 2016, The Society for Free Radical Research Japan

    Dr Juntaro Matsuzaki

  92. Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies forHelicobacter pyloriStrains Containing thegyrAMutation

    Article • Helicobacter, November 2015, Wiley

    Dr Juntaro Matsuzaki

  93. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

    Article • United European Gastroenterology Journal, November 2015, SAGE Publications

    Dr Juntaro Matsuzaki, Professor Hidekazu Suzuki

  94. Role of MicroRNAs-221/222 in Digestive Systems

    Article • Journal of Clinical Medicine, August 2015, MDPI AG

    Dr Juntaro Matsuzaki

  95. Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan

    Article • PLOS One, July 2015, PLOS

    Dr Juntaro Matsuzaki

  96. Faculty of 1000 evaluation for Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: a Systematic Review and Meta-Analysis.

    Article • July 2015, Faculty of 1000, Ltd.

    Dr Juntaro Matsuzaki

  97. Mo1405 The Aberrant Shape of Main Pancreatic Duct Increases the Risk of the Post ERCP Pancreatitis

    Article • Gastrointestinal Endoscopy, May 2015, Elsevier

    Dr Juntaro Matsuzaki

  98. Sa1887 Adiponectin Ameliorates Carcinogenic Pathway Depending on miR-221/222 in Esophageal Adenocarcinoma Cells

    Article • Gastroenterology, April 2015, Elsevier

    Dr Juntaro Matsuzaki

  99. Sa1933 Overexpression of CD44v9 in Gastric Cancer Cells Confers Resistance to Trastuzumab by Inducing Antioxidant Enzymes That Inhibit Tumor Cell Death Induced by Oxidative Stress

    Article • Gastroenterology, April 2015, Elsevier

    Dr Juntaro Matsuzaki

  100. Sa1086 Smoking, a Previous History of Malignancy, and the Presence of Barrett's Esophagus As Risk Factors for Adenoma and Carcinoma of the Duodenum

    Article • Gastroenterology, April 2015, Elsevier

    Dr Juntaro Matsuzaki

  101. Nordihydroguaiaretic Acid Disrupts the Antioxidant Ability ofHelicobacter pylorithrough the Repression of SodB ActivityIn Vitro

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Juntaro Matsuzaki

  102. Faculty Opinions recommendation of High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.

    Article • December 2014, F1000Research

    Dr Juntaro Matsuzaki

  103. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice andHelicobacter pylori-infected mice

    Article • Journal of Gastroenterology and Hepatology, December 2014, Wiley

    Dr Juntaro Matsuzaki

  104. Propofol versus traditional sedative agents for endoscopic submucosal dissection

    Article • Digestive Endoscopy, September 2014, Wiley

    Dr Juntaro Matsuzaki

  105. Sa1900 CD44v9 Results in Resistance to Trastuzumab via Induction of ROS Resistance

    Article • Gastroenterology, May 2014, Elsevier

    Dr Juntaro Matsuzaki

  106. 66 Neural Stem Cell Transplantation Restored the Delayed Gastric Emptying in Apolipoprotein E-Knockout Mice

    Article • Gastroenterology, May 2014, Elsevier

    Dr Juntaro Matsuzaki

  107. Sa1331 Efficacy and Safety of Rikkunshito, a Japanese Herbal Medicine, on the Treatment of Functional Dyspepsia: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

    Article • Gastroenterology, May 2014, Elsevier

    Dr Juntaro Matsuzaki

  108. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia-a multicenter, double-blind, randomized, placebo-controlled study

    Article • Neurogastroenterology & Motility, April 2014, Wiley

    Dr Juntaro Matsuzaki

  109. MicroRNAs in Barrett's esophagus: future prospects

    Article • Frontiers in Genetics, April 2014, Frontiers

    Dr Juntaro Matsuzaki

  110. Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persistvsresolve on medical therapy

    Article • Neurogastroenterology & Motility, February 2014, Wiley

    Dr Juntaro Matsuzaki

  111. Small Cell Neuroendocrine Carcinoma of the Esophagus Producing Parathyroid Hormone-related Peptide with Humoral Hypercalcemia

    Article • Nihon Naika Gakkai Zasshi, January 2014, Japanese Society of Internal Medicine

    Dr Juntaro Matsuzaki

  112. Bile Acids Increase Levels of MicroRNAs 221 and 222, Leading to Degradation of CDX2 During Esophageal Carcinogenesis

    Article • Gastroenterology, December 2013, Elsevier

    Dr Juntaro Matsuzaki

  113. Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial

    Article • United European Gastroenterology Journal, November 2013, SAGE Publications

    Dr Juntaro Matsuzaki

  114. Correction: Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication

    Article • PLOS One, July 2013, PLOS

    Dr Juntaro Matsuzaki

  115. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence

    Article • British Journal of Cancer, June 2013, Nature

    Dr Juntaro Matsuzaki

  116. Biliary Findings Assist in Predicting Enlargement of Intraductal Papillary Mucinous Neoplasms of the Pancreas

    Article • Clinical Gastroenterology and Hepatology, May 2013, Elsevier

    Dr Juntaro Matsuzaki

  117. Tu2095 Application of 13C-Acetic Acid Breath Test for Animals With Impaired Gastric Motility

    Article • Gastroenterology, May 2013, Elsevier

    Dr Juntaro Matsuzaki

  118. Tu1797 The Loss of Work Productivity Associated With Gastroesophageal Reflux Disease (GERD) in a Japanese Working Population

    Article • Gastroenterology, May 2013, Elsevier

    Dr Juntaro Matsuzaki

  119. Su1724 Expression of CD44 Variant 9 Contributes to 5-Fluorouracil Resistance in Gastric Cancer Through Anti-Oxidative Stress Mechanism

    Article • Gastroenterology, May 2013, Elsevier

    Dr Juntaro Matsuzaki

  120. Mo1849 Bile Acids Enhance Oncogenic miR-221/222 in the Transformation From Barrett's Esophagus to Adenocarcinoma

    Article • Gastroenterology, May 2013, Elsevier

    Dr Juntaro Matsuzaki

  121. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan

    Article • United European Gastroenterology Journal, April 2013, SAGE Publications

    Dr Juntaro Matsuzaki

  122. Enhancement of Amoxicillin Resistance after Unsuccessful Helicobacter pylori Eradication

    Article • Antimicrobial Agents and Chemotherapy, January 2013, ASM Journals

    Dr Juntaro Matsuzaki

  123. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy

    Article • Journal of Clinical Biochemistry and Nutrition, January 2013, The Society for Free Radical Research Japan

    Dr Juntaro Matsuzaki

  124. Reactive Oxygen Species-Induced Autophagic Degradation of Helicobacter pylori CagA Is Specifically Suppressed in Cancer Stem-like Cells

    Article • Cell Host & Microbe, December 2012, Elsevier

    Dr Juntaro Matsuzaki

  125. Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication

    Article • PLOS One, November 2012, PLOS

    Dr Juntaro Matsuzaki

  126. Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply

    Article • Journal of Neurogastroenterology and Motility, October 2012, The Korean Society of Neurogastroenterology and Motility

    Dr Juntaro Matsuzaki

  127. The tumor suppressormicroRNA-29cis downregulated and restored by celecoxib in human gastric cancer cells

    Article • International Journal of Cancer, October 2012, Wiley

    Dr Juntaro Matsuzaki

  128. Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs

    Article • Biochemical and Biophysical Research Communications, September 2012, Elsevier

    Dr Juntaro Matsuzaki

  129. Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

    Article • Journal of Neurogastroenterology and Motility, July 2012, The Korean Society of Neurogastroenterology and Motility

    Dr Juntaro Matsuzaki

  130. High frequency of overlap between functional dyspepsia and overactive bladder

    Article • Neurogastroenterology & Motility, May 2012, Wiley

    Dr Juntaro Matsuzaki

  131. Tu1155 The Extension of Mucosal Lesions, Helicobacter pylori Infection Status and API2-MALT1 Positivity are Associated With the Therapeutic Response for Gastric MALT Lymphoma

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  132. Su1082 GERDQ is Superior Tool for the Evaluation of GERD Symptoms and Unmet Medical Needs to the Carlsson-Dent Questionnaire - a Large Scale Survey -

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  133. Su1097 GERDQ is an Easy and Useful Tool for Assessing the Severity of Gastroesophageal Reflux Disease and Identifying Patients With “Unmet Medical Needs”

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  134. Mo1569 MicroRNA-21 Expression Causes Nuclear Loss of the Tumor Suppressor PDCD4 in Precancerous Gastric Adenomas

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  135. 616 Specific Amino Acid Mutation of p53 Enhanced the Stability of Intracellular CagA by Inhibiting Autophagy Induction

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  136. Su1612 Dynamics of Aquaporin-4 in Gastric Parietal Cells in the Hyperplastic Gastric Fundic Mucosa of Histamine Type 2 Receptor Knockout Mice

    Article • Gastroenterology, May 2012, Elsevier

    Dr Juntaro Matsuzaki

  137. FecA1, a bacterial iron transporter, determines the survival of Helicobacter pylori in the stomach

    Article • Free Radical Biology and Medicine, March 2012, Elsevier

    Dr Juntaro Matsuzaki

  138. Reduced ghrelin production induced anorexia after rat gastric ischemia and reperfusion

    Article • AJP Gastrointestinal and Liver Physiology, February 2012, American Physiological Society

    Dr Juntaro Matsuzaki

  139. Classification of functional dyspepsia based on concomitant bowel symptoms

    Article • Neurogastroenterology & Motility, January 2012, Wiley

    Dr Juntaro Matsuzaki

  140. Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

    Article • Antimicrobial Agents and Chemotherapy, December 2011, ASM Journals

    Dr Juntaro Matsuzaki

  141. Helicobacter pylori Resistance to Rifabutin in the Last 7 Years

    Article • Antimicrobial Agents and Chemotherapy, September 2011, ASM Journals

    Dr Juntaro Matsuzaki

  142. Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy forHelicobacter pylorieradication?

    Article • Expert Review of Clinical Pharmacology, September 2011, Taylor & Francis

    Dr Juntaro Matsuzaki

  143. What Is the Difference Between -Associated Dyspepsia and Functional Dyspepsia?

    Article • Journal of Neurogastroenterology and Motility, April 2011, The Korean Society of Neurogastroenterology and Motility

    Dr Juntaro Matsuzaki

  144. Enhancement of Amoxicillin Resistance after Unsuccessful Helicobacter pylori Eradication

    Article • Antimicrobial Agents and Chemotherapy, April 2011, ASM Journals

    Dr Juntaro Matsuzaki

  145. Dysfunctional Gastric Emptying With Down-regulation of Muscle-Specific MicroRNAs in Helicobacter pylori-Infected Mice

    Article • Gastroenterology, January 2011, Elsevier

    Dr Juntaro Matsuzaki

  146. Two Amino Acids Mutation of Ferric Uptake Regulator DeterminesHelicobacter pyloriResistance to Metronidazole

    Article • Antioxidants & Redox Signaling, January 2011, Mary Ann Liebert Inc

    Dr Juntaro Matsuzaki

  147. Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori

    Article • Biochemical and Biophysical Research Communications, January 2011, Elsevier

    Dr Juntaro Matsuzaki

  148. Etiological difference between ultrashort- and short-segment Barrett’s esophagus

    Article • Journal of Gastroenterology, December 2010, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  149. Clinical results of observation of the upper gastrointestinal tract by transgastrostomic endoscopy using an ultrathin endoscope

    Article • Journal of Gastroenterology and Hepatology, November 2010, Wiley

    Dr Juntaro Matsuzaki

  150. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn

    Article • Neurogastroenterology & Motility, May 2010, Wiley

    Dr Juntaro Matsuzaki

  151. S1630 Caudal-Related Homeobox 2 (CDx2) Suppresses Stratification of Esophageal Squamous Epithelial Cells by Down-Regulating MicroRNA-221/222

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  152. M1139 Sitafloxacin-Based Third-Line Eradication of H. pylori

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  153. M1909 Increased Expression of MicroRNA-21 is an Early Event in Human Gastric Carcinogenesis

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  154. 884 The Role of the Ferric Uptake Regulator (Fur) in Helicobacter pylori Resistance to Metronidazole

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  155. S2063 Impaired Heme Oxygenase-1 Induction in the Gastric Antrum of Streptozotocin-Induced Diabetic Rats

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  156. T1700 Dyslipidemia is a Risk Factor for NERD, but Not for Functional Heartburn

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  157. T1766 Transient Gastroparesis and Reduced Ghrelin After Gastric Ischemia and Reperfusion

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  158. 180 Induction of H. pylori Resistance to Metronidazole Through Enhanced Expression of a Bacterial Efflux Pump

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  159. W1751 MicroRNA-21 Plays a Critical Role in Helicobacter pylori-Associated Gastric Cancer by Suppressing Btg2

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  160. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy

    Article • Journal of Gastroenterology and Hepatology, May 2010, Wiley

    Dr Juntaro Matsuzaki

  161. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori

    Article • Journal of Gastroenterology and Hepatology, May 2010, Wiley

    Dr Juntaro Matsuzaki

  162. Acid Suppression by Proton Pump Inhibitors Enhances Aquaporin-4 and KCNQ1 Expression in Gastric Fundic Parietal Cells in Mouse

    Article • Digestive Diseases and Sciences, May 2010, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  163. M1346 High Prevalence of Lower Gastrointestinal (GI) Symptoms in Functional Dyspepsia: A Factor and Cluster Analysis in the General Population

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  164. 18 Overexpression of Mir-142-5p and Mir-155 and Suppression of Tumor Protein 53-Induced Nuclear Protein 1 in Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  165. 266 Chronic Infection With Helicobacter pylori Induces Downregulation of Muscle-Specific MicroRNAs and Smooth Muscle Hypertrophy of the Mouse Stomach

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  166. W1749 Downregulation of the Tumor Suppressor MicroRNA-29c Plays a Critical Role in the Progression of Human Gastric Cancer

    Article • Gastroenterology, May 2010, Elsevier

    Dr Juntaro Matsuzaki

  167. Ghrelin and oxidative stress in gastrointestinal tract

    Article • Journal of Clinical Biochemistry and Nutrition, January 2010, The Society for Free Radical Research Japan

    Dr Juntaro Matsuzaki

  168. Delayed gastric emptying and disruption of the interstitial cells of Cajal network after gastric ischaemia and reperfusion

    Article • Neurogastroenterology & Motility, December 2009, Wiley

    Dr Juntaro Matsuzaki

  169. Gallstones increase the prevalence of Barrett’s esophagus

    Article • Journal of Gastroenterology, November 2009, Springer Science + Business Media

    Dr Juntaro Matsuzaki

  170. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells

    Article • Oncogene, June 2009, Nature

    Dr Juntaro Matsuzaki

  171. 977 Sitafloxacin and Garenoxacin, New-Generation Quinolones, Can Overcome the Antibiotic Resistance of H. pylori with gyrA Mutations

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  172. M1051 Efflux Pumps Contribute to Clarithromycin Resistance in H. pylori

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  173. 129 Ferric Uptake Regulator (FUR) Mutation in Helicobacter pylori Associated with the Development of Resistance to Metronidazole: Implication of the Structural-Functional Relationships of Mutant-Type Fur

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  174. T1779 Enhanced Ghrelin Secretion and Gastric Excitatory Neural Network in Rats with Gastric Outlet Obstruction

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  175. 47 Gastric Acid Secretion Suppression Enhanced Aquaporin-4 and KCNQ1 Expressions in the Fundic Parietal Cells

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  176. W1953 MicroRNA-142 and -155 Are Novel Molecular Markers for Gastric MALT Lymphoma with API2-MALT1 FUSION

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  177. 93 Enhanced Esophageal NADPH Oxidase 3 Expression and Free Radical Production in Response to Acid

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki

  178. 1088 Role of MicroRNA-29c in the Chemoprevention of Gastric Cancer By a Selective COX-2 Inhibitor

    Article • Gastroenterology, May 2009, Elsevier

    Dr Juntaro Matsuzaki